Multicenter comparative study to examine the efficacy of zoledronic acid in prostate cancer with bone metastasis at different hormone sensitivity status.
Not Applicable
Recruiting
- Conditions
- Prostate cancer with bone metastasis
- Registration Number
- JPRN-UMIN000002792
- Lead Sponsor
- Tama Prostate cancer Bone metastasis Study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1.History of hypersensitivity for zoledronic acid or other bisphosphonate 2.Renal dysfunction(serum creatinine more than 3.0mg/dL) 3.Active concomititant malignancy 4.Severe coexisting disease 5.Invasive dental treatment within 3 months 6.Other bisphosphonate therapy for injection within 6 months 7.Not suitable for this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method